Global collaborative centre for medical countermeasures breaks ground in Navi Mumbai

TechInvention Lifecare Pvt Ltd announces the ground-breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC), with an investment of approx. US$15 million. The centre, strategically located near the upcoming international airport in Navi Mumbai, aligns with global health initiatives and aims to facilitate the entire cycle of vaccine development, biotherapeutics, and diagnostics for human and veterinary segments. Recognised for its global significance at the 2nd World Local Production Forum, GCMC supports the One Health approach, emphasising the interconnectedness of human, animal, and environmental health.

This facility will serve the needs of both public and private organisations, such as academic institutes, start-ups, MSMEs, and R&D organisations, to provide a comprehensive ecosystem, facilitating the transition from R&D to GMP-scale production for pre-clinical/clinical batches with required regulatory approvals.

Syed S. Ahmed, Director and CEO of TechInvention, stated: “GCMC would be the needed intervention, strengthening the hubs by providing 'scaled-up,' regulatory-approved, cost-effective, and free of IP infringement biosolutions sourced from both indigenous research and centres of excellence worldwide.”

More information online